Search

I medici più attivi

Ultimi articoli

Dr.ssa giulia veronesi

Dr.ssa giulia veronesi

Specialista in Chirurgia dell'apparato digerente e Chirurgia toracica

Medico Specialista Convenzionato
Milano (MI) | Vedi mappa
7 Risposte |
follower
La Dott.ssa Giulia Veronesi è responsabile della Chirurgica Toracica Robotica presso l’Ospedale Humanitas di Milano. In precedenza ha diretto l’unità di ricerca screening e prevenzione del tumore polmonare presso lo IEO dove ha lavorato per 15 anni come chirurgo toracico oncologico. Dal 2004 ha guidato un ampio programma di screening del tumore ai polmoni (gli studi di COSMOS) utilizzando la tomografia a basso dosaggio e i marcatori in individui ad alto rischio. Dal 2006 ha sviluppato un programma di chirurgia robotica per il trattamento del tumore polmonare dei tumori del mediastino, della miastenia e delle patologie esofagee. Ha eseguito attività di tutoraggio in chirurgia robotica presso diversi centri in Italia e Europa inclusa l’Università di Ginevra. Ha progettato e coordinato un trial randomizzato multicentrico internazionale di confronto tra chirurgia robotica e videotoracoscopica manuale attualmente in corso per il trattamento del tumore polmonare e ha avviato un gruppo di lavoro presso la Società europea di chirurgia toracica (ESTS) sulla chirurgia robotica di supporto alla ricerca e il training in questo campo. E’ stato investigatore principale di diverse sperimentazioni finanziate dal National Cancer Institute americano focalizzate principalmente sulla farmaco prevenzione del tumore del polmone, tra cui lo studio randomizzato sulla Budesonide per via inalatoria rispetto al placebo per i noduli polmonari rilevati con screening e la sperimentazione di prevenzione tumorale a doppio cieco che valuta il ruolo dell'aspirina giornaliera a bassa dse (100 mg) in soggetti sani con lesioni pretumorali al polmone. E’ consigliere nel consiglio di amministrazione della fondazione Umberto Veronesi con sede a Milano. È membro di diversi comitati editoriali di riviste internazionali e di diverse società scientifiche europee e internazionali. Ha visto il premio donne e tecnologie nel 2017 come tecnovisionaria per l’attivita robotica e di screening del tumore polmonare. È stata relatore ad oltre 110 conferenze nazionali ed internazionali ed è autrice di 170 articoli scientifici e autori di 8 capitoli di libri con un HI di 30 e IF del 645.
Leggi il curriculum
Specialista in
Chirurgia toracica, Chirurgia dell'apparato digerente
Ultime risposteLeggi tutto
Dove ricevo
Studio medico privato
Humanitas Research Hospital
Via Manzoni 56
20089 - Milano (MI)
0282248224
Ente
Humanitas
VIA MANZONI
20089 - Milano (MI)
3398404074
Curriculum

Curriculum vitae and Bibliography

Date of preparation: October 2015

A.             GENERAL INFORMATION

1.              Giulia Veronesi

2.              Office address, telephone, fax:

3.              Humanitas Research Hospital, Via Manzoni 56– 20089 Rozzano (Italy), 0039 02 82247396

4.              Home address: Via Paolo Frisi 3 – 20129 Milan

5.              Cell phone: 0039 339 8404074

6.              Email: giulia.veronesi@humanitas.it

7.              Citizenship: Italian

8.              VRNGLI69M58F205Y

9.              Optional Information:

a.              Date of birth: August 18th, 1969

b.              Place of birth: Milan, Italy

c.              Marital status: Married

d.              Spouse’s name: Pietro Paolo Bianchi

e.              Children’s names and ages: Lorenzo (11 years old), Francesca (9 years old), Matteo (5 years old)

  1. Race/Ethnicity: Caucasian

B.             EDUCATIONAL BACKGROUND

Degree

Institution name

Institution location

Dates Attended

Year Awarded

Medical Degree

Università degli Studi di Milano

Milan

September 1988-July 1994

July 1994

Residency in General Surgery

Università degli Studi di Milano

Milan

1995-2000

2000

Fellowship

European Board of Thoracic and Cardiovascular Surgeons

ESTS-EACTS Annual meeting- Instambul

2002

 

2002

Residency

Università degli Studi di Modena

Modena

2001-2006

2006

National Scientific License for Associated Professor in Thoracic Surgery

Ministry of Eductation, University and Research

Italy

2013

2013

                                                           

  1. PROFESSIONAL POSITIONS AND EMPLOYMENT

August 1994-August 1995     Post Graduate Internship at the Department of General and Thoracic Surgery at S. Giuseppe Hospital in Milan (Prof. G.C. Roviaro)

Sept 1995-Feb 1997 Resident at School of General Surgery Department of General and Thoracic Surgery at S. Giuseppe Hospital in Milan (head Prof. G.C. Roviaro)

March 1997-Sept 1997 Resident at Institute of General Surgery and Surgical Oncology at the Ospedale Policlinico of the University of Milan directed by Prof. A. Peracchia

Oct 1997-June 1998   Resident at Department of General and Minimally-Invasive Surgery - Istituto Clinico Humanitas in Milan (Head Dott. R. Rosati)

July 1998- Nov 1998  Resident at Division of Senology European Institute of Oncology Milan (head: Dott. A. Luini)

Dec 1998- May 2000 Resident in the Division of Thoracic Surgery European Institute of Oncology, Milan (head U. Pastorino)

May – Nov 2000 Internship as assistant Surgeon in the Division of Thoracic Surgery Institut Mutualiste Mountsouris, Paris (head Prof. D. Grunenwald)

Hospital positions

Nov 1997- Jan 1998   Visiting Physician at Department of Surgery The New York Hospital Cornell University (Prof. D. Skinner) and Division of Laparoscopic Surgery Mount Sinai Hospital New York (head: Dott. B. Salky)

Feb 2001- Dec 2002   Assistant Surgeon at Division of Thoracic Surgery European Institute of Oncology, Milan (head  U. Pastorino)

Jan 2003- March 2004 Senior Assistant at Division of Thoracic Surgery European Institute of Oncology, Milan (head  L. Spaggiari)

March 2004-Dec 2009            Deputy Director Division of Thoracic Surgery European Institute of Oncology, Milan

Jan 2010- Aug 2015 Director Unit of Lung Cancer Early Detection at the Division of Thoracic Surgery European Institute of Oncology, Milan

D.            PROFESSIONAL MEMBERSHIPS (medical and scientific societies)

 

1.              Member of European Society of Thoracic Surgery 2001–  2015

2.              Member of European Association of Cardio Thoracic Surgery  2010–  2015

3.              Founding Member of Clinical Robotic Surgeon Association  2008–  2015

4.              Member of International Association Study of Lung Cancer  2008– 2015

5.              Member of the the International IASLC Strategic Screening Advisory Committee (SSAC)

6.              Member of the Italian Society of Thoracic Surgery (SICT)

7.              Member of the Editorial board of: 1) Lung Cancer; 2) ecancermedicalscience; 3) Frontiers in Oncology

8.              Member of European Society of Medical Oncology (ESMO) since January 2014 . Member of the ESMO Guidelines Working Group on early stage and locally advanced lung cancer

9.              Member of the European Thoracic Oncology Platform (ETOP)

10.           Member of the Italian Association Women and Technology.

11.           Faculty member of the School  of Robotic Surgery of the Italian Society of Surgery (SIC) since October 2015

 

E.             INSTITUTIONAL/HOSPITAL AFFILIATION

 

1.              Chief  Robotic Surgery Unit at the Division of Thoracic and General Surgery , Humanitas Research Hospital , Rozzano, Via Manzoni 56, 20089 Rozzano, Milan

 

F.             STATUS

1.              Name of Current Employer(s): Humanitas Research Hospital

2.              Employment Status: Full-time salaried

 

G.            CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES AND PERCENT EFFORT

Teaching

She was faculty member of the IEO School of Robotic Surgery and scientific responsible of annual courses on robotic thoracic surgery at IEO.

She was the scientific responsible of a Course on Lung Cancer Screening held at IEO in March 2013

She is the coordinator of the thoracic session at the annual international meeting  of the CRSA  from 2011 to 2014 .

She is member of the faculty of the EACTS robotic group.

She is member of the faculty of ESTS course in Thoracic Surgery held in Elancourt Paris, 2013 (two sessions) and 2014 (one session). Member of the ESTS committee for Learning Affairs

She is proctor of robotic thoracic surgery in Geneve, University Hospital and in different places in Italy

She has experience as teacher of Thoracic Surgery  and Esophageal Surgery in different courses held by the University of Milan for residents in thoracic surgery, in general surgery and for  radiology technician and nurses.

1.              Clinical care

She performs all kind of oncological thoracic surgery operations including standard and extended resections.

The thoracic surgery activity during the period 1999-2013 included 2408 operations of which 1514 as first surgeon. In detail: 572 lobectomies or bilobectomies plus lymph node dissection, 342 sublobar resection wedge or segmental resection, 76 pneumonectomies, 158 mediastinoscopy or mediastinotomy, 74 pleural or mediastinal lesions biopsy,  8 esophagectomies,   34 rescetion of thymomas or other mediastinal lesions. About 240 lung major resections and 20 mediastinal resections have been performed using the robotic system.

Clinical practice activity in thoracic surgery includes evaluation of the clinical outline of oncologic surgical and pre surgical patients (4 days/week, 600 patients/year).

 Administrative duties, including committees, dates

Research:

Principal Investigator in Italian Multicenter Study for Lung Cancer Screening with Low Dose CT and Molecular Markers.

Co-PI in Phase III Randomized trial of Limited Resection versus standard lobectomy for Early Stage Lung Cancer.

Principal Investigator in Randomized phase II trial of Budesonide Turbuhaler 800 micrograms/twice daily versus placebo in high-risk.

Co-investigator in Identification and Isolation of Normal and Tumoral Lung Stem Cells as a tool for the definition of new study.

Co-investigator in Analytical and clinical validation of functional imaging for early non-invasive cancer diagnosis study.

Principal Investigator in Evolution of Undeterminated CT – detected lung nodules, among a randomized phase II trial inhaled Budesonide.

PI: Randomized Phase II Trial of Low dose Aspirin versus Placebo in High-Risk Individuals with CT Screen Detected Subsolid Lung Nodules

Co Pi: Benefits of Tobacco Free Cigarette among heavy smokers undergoing a lung cancer screening program: a Randomized Control Study

PI: Development of an Integrated System for the surveillance of workers  exposed to professionas cancerogens. Collaboration with Inail

 

Current Percent Effort (%)                              Does the activity involve WCMC students/researchers? (Yes/No)        N/A

Clinical Care 50%

Administration 10%

Research, Education 40%

TOTAL:  100%

  1. RESEARCH SUPPORT

 

- NCI DCP Protocol Number: MDA2013-01-01 Randomized Phase II Trial of Low dose Aspirin versus Placebo in High-Risk Individuals with CT Screen Detected Subsolid Lung Nodules

- AIRC,  2012-2014, Lung Cancer Early Detection with Low Dose CT scan and Molecular Markers. Dr. Giulia Veronesi, Role: Principal Investigator (30%)

- NCI DCP Protocol Number: MDA05-5-03; PI: G. Veronesi 30/9/2011-29/9/2012 Evolution of Underterminated  CT- detected lung nodules, among a randomized phase II trial with inhaled Budesonide. Dr. Giulia Veronesi, Role: Principal Investigator

- MinRO strategici 5/07; Ministry of Health;  PI: F. Podo    10/03/2008-09/03/2012 Analytical and clinical validation of functional imaging for early non-invasive cancer diagnosis.Role: coinvestigator

- RF 2007 n51; Ministry of Health;  PI: PG. Pelicci  01/02/2009-31/01/2011 Identification and isolation of normal and tumoral lung stem cells as a tool for the definition of new therapeutic strategies in lung cancer Role: coinvestigator

- NCI DCP Protocol Number: MDA05-5-01; 2006-2008, Randomized phase II trial of Budesonide Turbuhaler 800 micrograms/twice daily versus placebo in high-risk population with undetermined lung nodules detected at screening low dose CT scan. Dr. Giulia Veronesi, Role: Principal Investigator

  1. EXTRAMURAL PROFESSIONAL RESPONSIBILITIES

 

  1. A February, 25th 2000            "Smoking and lung cancer"  in Milanoncologia 2000,  Workshop. European Institute  of Oncology. Milan
  2. A Aug 30th - Sept 3rd 2000     “Bronchoplastic procedure after induction chemotherapy”. World Congress on Lung Healt and 10th ERS Annual Congress Florence
  3. A  October 2000          “Bronchoplastic procedure after induction chemo/radiation therapy”. 9th World Conference on Lung Cancer. Tokio
  4. A  November, 1st - 3rd 2000    “Surgical treatment of lung metastases: the role of preoperative FDG-PET”. 8th European Conference on General Thoracic Surgery. London      
  5. IS Novembre, 2000      "Chemoprevention in Lung Cancer " seminario sulla farmacoprevenzione dei tumori. European Institute  of Oncology. Milan
  6. IS March 4-6th  2001  “Surgery and prognosis of lung metastasis”. IV National Conference AIOM. Colorectum Cancer. Bologna
  7. IS October 5th 2001    “Surgical treatment of Thoracic tumors infiltrating the aorta”. Vascular Surgery Meeting. International Heart School. Bergamo.
  8. IS September 18th 2002                      “Screening  of lung cancer with low dose CT scan”. ESO school . Maddalena. Italy 
  9. IS April, 29th  2004    “New trends in the surgical resection of early stage NSCLC”. European Institute of Oncology
  10. IS June 26th  2004                  “NSCLC: staging technique, surgical indication and perspective of cure”. Maugeri Foundation. Pavia
  11. September 17th –18th  2004    “Surgical treatment of SCLC”.First Milan Lung Cancer Conference, Milan
  12. IS September 17th –18th  2004           “Treatment strategies of early stage lung cancer”. Lilly Satellite  Simposium First Milan Lung Cancer Conference, Milan                         
  13. IS November 2004 “Spiral CT for early detection of lung cancer”.  Ispes-EIO congress on cancer and work exposure.
  14. IS November 2005 Cosenza Aiom: Il trattamento chirugico del tumore polmonare: dalla diagnosi precoce alla terapia multimodalica.
  15. IS October 2005 Bucarest: Thoracic Surgery Conference. Anterior approach for apical chest tumors.
  16. A October 2005 Chicago STS.  Combined Hemiclamshell and transmanubrial approaches for apical chest wall
  17. A June 2006 Asco meeting:  Atlanta. Low dose CT for early diagnosis of lung cancer: results of baseline screening in 5000 high risk volunteers       
  18. A June 2006 WTSA: Sun Valley. Prognostic role of lymph nodes involvement in lung metastasectomy
  19. IS September 21st, 2006          Vesuvian interactive  thoracic course: Naples. The real significance of lung cancer screening programs.
  20. IS Sept 2007 IASLC 12th world conference on lung cancer.  Seoul South korea Nodule detection using assisted computed diagnosis.
  21. IS January, 9th,  2008             EACTS course of robotic surgery in Stransburg. Lobectomy for lung cancer:  one year experience
  22. A Janaury, 24-26th , 2008       MIRA Congress 2008, Rome.  Robotic Thoracic Surgery, Early experience in the treatment of lung cancer.
  23. IS June 19-20th, 2008             Zagreb “Lung cancer workshop” : Screening programs for lung cancer
  24. IS September, 9th, 2008          Bari: Lung cancers screening with low dose CT scan
  25. IS November,16-19th  2008     7th Annual AACR International Conference Washington. Budesonide Randomized phase II trial of Budesonide Turbuhaler 800 mg/twice daily versus placebo in high-risk population with undetermined lung nodules detected at screening low dose CT scan
  26. IS December, 5-6th 2008         Barletta conference on lung cancer. Robotic Thoracic Surgery            IEO experience in the treatment of lung cancer
  27. IS January, 2009         EACTS course of robotic surgery in Strasburg: Robotic lymph node dissection in the treatment of lung cancer
  28. IS May 13th , 2009      The 89th Annual Meeting of AATS Boston USA.  Four arm robotic lobectomy for the treatment of early stage lung cancer.
  29. IS April , 27th 2009     20th Conference I-ELCAP – Washington. The COSMOS trial
  30. IS October, 10th 2010             La chirurgia robotica in oncologia. Istituto Europeo di Oncologia, Milano
  31. IS October, 11th  2009            Learning curve and oncological radicality in robotic lobectomies. The 1ST  CRSA Meeting Chicago 9-10 October, 2009
  32. A 20th March 2010      Ancillary Studies in CT Screening for Lung Cancer: Randomized treatment trial using budesonide and genomics . The 22nd International Conference On Screening For Lung Cancer  March 19-March 21, 2010., Phoenix           
  33. IS 2nd  May 2010        “Learning curve in robotic lobectomies” AATS 90th annual meeting Toronto, 2-5 May 2010
  34. IS 17th-18th June 2010           The ISMICS meeting , Berlin” Robotic lobectomy: standard technique and pitfalls”
  35. IS 22-24 June 2010     Director of the First Milan Course of Robotic Thoracic Surgery. Milan IEO.
  36. IS 11th – 15th September 2010           EACTS annual meeting Geneve. “Learning curve in robotic lobectomies” “Update in lung cancer screening”
  37. IS 20-22nd  September 2010   The 2nd International VATS LOBECTOMY MEETING .The Royal College of Surgeons of Edinburgh “ Robotic lobectomies: technique and results”.
  38. IS 1-2 Oct 2010           CRSA meeting. Chicago. Invited speaker on “Robotic segmentectomy for lung cancer“
  39. IS 22 Oct  2010           23rd international conference of I-ELCAP , New York. “Lung cancer risk prediction for smokers undergoing screening based on the COSMOS trial “ “Overdiagnosis in CT screening for lung cancer “
  40. IS October 27-29, 2010                       Consensus Meeting 2010 Square Brussels Meeting Centre “Robotic lung lobectomy”.
  41. IS February 22-23 2011          Strasburg EACTS master in Robotic Cardiothoracic Surgery. Anatomy and trocar position of robotic  lobectomies
  42. IS 3-4 March 2011      Pisa  Lo screening per il tumore polmonare: stato dell’arte. Consensus meeting italiano. “Cosmos study “ invited speaker.
  43. IS 15 April  2011         Rionero in Vulture. Prospettive della condotta medico chirurgica delle neoplasia del torace. Lung Surgery with the Robot Da Vinci System
  44. IS 4 Nov 2011  3rd annual CRSA conference: Houston.  Invited speaker: the utility of robotics in the management of CT detected pulmonary nodules.
  45. IS April, 2012 Invited speaker at ELLC organized by European Society of Medical Oncology: “Update on european lung cancer screening studies”  Geneve 20th
  46. IS 15th April 2012       Torino Invited Speaker at Snamid Conference: “Lung Cancer Early Detection”
  47. IS 27th  January 2012             Invited speaker: “Early detection of lung cancer with low dose CT”
  48. IS Febr 16- 2012. “Utility of Robotics in the management of screening detected nodules” Second Annual Miami Robotic Symposium. Miami , Florida.
  49. IS 26th Sept 2012 Invited speaker: “Lung nodules management among screening programs”  at the Joined Conference of the Italian Surgical Societies
  50. IS 29th September 2012          4rd CRSA conference: Chicago Invited speaker. “Robotic approach and limited resection for lung cancer”.
  51. IS 26th and 27th October 2012           1st International Conference on Minimally Invasive and Robotic Surgery: San Paolo, Brasil. Invited speaker for the following presentations: -Current limitations of robotic surgery in a thoracic center; - Learning curve in robotics: when experience matters? -        Robotic approach to mediastinal diseases – step by step; -      The role of robotic approach in the management of screening detected cancers;  -      Robotic challenges in Segmentectomy for lung cancer;  -Oncological outcome of robotic lobectomy, results of multicenter study.
  52. IS December 17th, 2012          Invited speaker. “Therapeutic innovations in Oncology at the threshold of 2013”, Bari
  53. IS January 19th, 2013 Invited speaker. “Lesser resection than lobectomy” at the Annual Winter Oncology Symposium of the Lung Oncological Network Ghent (LONG)
  54. IS April 11th – 12th, 2013         Invited speaker at the ''Alimentazione, Attivita' Fisica,Fumo,Alcool,Tumore, Prevenzione,Diagnosi E Terapia '' in Andria (BT).
  55. IS April 22nd – 23rd, 2013      Course Director. “Course on Vats and Robot-assisted Surgery in Thoracic Oncology” at the European Institute of Oncology, Milan.
  56. IS May 2nd, 2013        Invited speaker. “Robotics in Thoracic Surgery” at the Israel Society of Pulmonology – Annual Meeting
  57. IS May 9th – 11th, 2013          Invited Speaker. “What are the requirements for a Thoracic Oncologic Centre?” at the European Multidisciplinary Conference in thoracic Oncology
  58. IS May 24th – 25th, 2013        Invited Speaker. “Il parere del chirurgo toracico” at the Annual meeting of SIRM.
  59. IS May 28th, 2013       Invited speaker. “CT screening for Lung Cancer and Surgical consequences” at the 21st European Conference on General Thoracic Surgery. ESTS Birmingham. 
  60. IS June 12th, 2013      Invited Speaker. “Robotic versus Open Thoracic Surgery” at the 2013 ISMICS Cardiac Masters Day.
  61. IS June  15th, 2013     Invited Speaker. “Major robotic pulmonary resection: learning curve and training” at the XXV National Conference of SPIGC
  62. IS Nov 2013 Invited Speaker European Network for Lung Cancer Screening. ETOP meeting Barcelona.
  63. IS 24-25th Jan 2014 “Robotic Surgery and minimally invasive techniques for lung cancer treatment” and “Review of available data on lung cancer screening “. Samo interdisciplinary Workshop on Chest Tumors, Lucerne
  64. IS Feb 2014  Invited Speaker Ests School of Thoracic Surgery” Robotic lobectomy: technical aspect  “ and “Robotic segmentectomy: technical aspect “ Elancourt, Paris
  65. C March 2014  Geneve  The fourth European Lung Cancer Conference (ELCC). Chair in the session Screening, Staging and epidemiology
  66. IS April 2014 Round Table eHealthall: ”Prevention, Nutrition and Technology. Assolomnbarda Milano
  67. IS June 2014   Invited speaker.  Robotic Session  “An up-to-date overview of the state of the art of robotic thoracic surgery “. ESTS annual meeting. Copenhagen
  68. IS June 2014 Invited Speaker Lung cancer screening. “How to minimize morbidity for the work up of screening nodules”. ESTS annual meeting. Copenhagen
  69. IS Oct 2014 “ Chemoprevention trials within LDCT screening”  at the workshop European Reccomendation for biomarker based chemoprevention trials, Milan 
  70. IS 8th September 2014 “Why surgery should  remain the standard of care in stage I patients which are operable”. Estro meeting , Florence 
  71. IS September 2014 “The place of less invasive surgery in the treatment of lung cancer” Esmo, Madrid.
  72. IS Octber 2014  Mesotelioma malign della pleura
  73. IS 3rd Dec 2014 “How to reduce invasiveness of screen detected lung cancer: characteristic of screen nodules and role of sublobar resection”. Expert meeting, Bari
  74. IS 5-6 Decembre 2014 Invited Speaker: “The risk of surgery”. Course on Lung cancer screening. “Integrating 20 years of experience in lung cancer screening into everyday  practice”. New York, Mount Sinai  Hospital,
  75. IS April 2015 “Robotic assisted surgery in lung cancer”Conference of thoracic disease , Antalya, Turkey
  76. IS June 2015 “Screening del tumore polmonare , criteri di fattibilità e insegnamenti “. Aipo, Bologna
  77. IS  1 July 2015. “Screening programs in Italy and results of European studies” Worshop su prevenzione e sorveglianza oncologica  nei soggetti con esposizione lavorativa all’amianto: lo screening del tumore polmonare, Milano
  78. IS 1 June 2015 “Vats and RATS current trends and superiorities”ESTS Lisbon Portugal
  79. IS April 2015 “The diagnostic Challenge of small nodules: can biomarkers be of help in the diagnosis”, ELCC Geneve 
  80. IS April 2015 “Surgery of multifocal lung tumors “ ELCC Geneve
  81. IS Sept 2016 Indication of surgery in lung cancer screening WCLC Denver 
  82. IS Sept 2015  Lung cancer Screening : ready for standard of care in Europe.  ESMO meeting Vienna
  83. IS October 2015 Espo meeting Milan. Lung cancer screening , Villa Necchi
  84. IS October 2015  State of the art and perspective of lung cancer screening with low dose CT, Milan.Lilt meeting “nuove prospettive negli screening oncologici”

 

J.              BIBLIOGRAPHY

BOOK CHAPTERS:

- G. Veronesi, L. Spaggiari. La chirurgia del tumore mammario localmente avanzato in Chirurgia della Mammella, Piccin Editori

- L. Spaggiari G. Veronesi, RF Kuenzer Caetano da Silva. Robotically assisted pneumonectomy for lung cancer. Minimally Invasive Thoracic Surgery. Springer.

- G. Veronesi. Lung Cancer Therapy Annual 7 edited by Professor Rolf A. Stahel. In press

- R. Cerfolio, G.Veronesi, A. Briant.  Robotic Techniques and Results for Resection of Lung Cancer. Thoracic Oncology:  The IASLC Multidisciplinary Approach Editors: Harvey Pass, David Ball, Giorgio Scagliotti. In press

- G. Veronesi. Robotic Thoracic Surgery. In Robotic Surgery: Current Applications and New Trends. Giuseppe Spinoglio (Ed.). In press

 

PUBLICATIONS:

 

1          Donati V., Lasagna G., Veronesi G. et al. Fetal Surgery: State of the Art. Chirurgia Italiana 1995; 47 (4) 49-55

2          Rebuffat C. Varoli F., Roviaro G.C., Vergani C., Maciocco, Veronesi G. L'Appendicectomie par Voie Videolaparoscopique. Tecnique et Resultats. A propos de 431 Cas. Le Journal De Celio-Chirurgie. 1995

3          Roviaro G.C., Roviaro G.C., Varoli F., Veronesi G et al. Videothoracoscopic Major Pulmonary Resections. In Toouli, Gossot, Hunter. Endosurgery. Churchill Livingston Ed. 1996

4          Rebuffat C., Roviaro G.C., Varoli F., Veronesi G et al. Videothoracoscopic Anatomy of Pulmonary Hilum In Toouli, Gossot, Hunter. Endosurgery. Churchill Livingston Ed. 1996

5          Veronesi G., Spaggiari L., Mazzarol G., Pastorino. Huge Malignant Localized Fibrous Tumor of the Pleura Journal of Cardiovascular Surgery . 2000;41:781-4; IF 0.573

6          Veronesi G., L. Spaggiari, P.G. Solli e U. Pastorino. Cardiac dislocation after extended pneumonectomy with pericardioplasty European Journal of Cardiothoracic Surgery. 2001; 19:89-91; IF 1.676

7          Veronesi G., F. Leo, P.G. Solli, M. D'Aiuto, F. D'Ovidio, G. Mazzarol, L. Spaggiari, U.Pastorino.  Life- treatening giant mediastinal goiter: a surgical challenge. Journal of Cardiovascular Surgery  2001, 42 (3): 429-30; IF 0.550

8          Zurrida S., V. Galimberti, B. Gibelli, A. Luini, S. Gianoglio, MT Sandri, R. Passerini, P. Maisonneuve, P. Zucali, G. Veronesi, F. Pigatto, U. Veronesi. Timing of breast cancer surgery in relation to the menstrual cycle:an update of developments. Critical review in Oncology /Hematolgy. 2001;38:223-230;

9          Torrisi R, Baglietto L, Johansson H, Veronesi G, Bonanni B, Guerrieri-Gonzaga A, Ballardini B, Decensi A. Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer. Br J Cancer 2001 Dec;85(12):1838-41; IF 3.942           

10        Grunenwald  DH, MDa, C Mazel, P. Girard, G. Veronesi, L. Spaggiari, D. Gossot, D. Debrosse, R. Caliandro,  J.L. Le Guillou, T. Le Chevalier, Radical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc Surg 2002;123:271-279;IF 2.842

11        Veronesi G, MD, Solli PG, Leo F, D'Aiuto M, Pelosi G, Leon M, De Braud F, Spaggiari L and Pastorino U. Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer. Lung Cancer 2002;36:91-7; IF 2.451

12        Orecchia R, Galimberti V, Luini A, Giannetti I, Ballardini B, Amadori A, Veronesi G, Veronesi U. Axillary radiotherapy instead of axillary dissection: a randomized trial. Zurrida. Italian Oncological Senology Group. Ann Surg Oncol. 2002 Mar;9(2):156-60.

13        Veronesi G, Landoni C, Pelosi G, Picchio M, Sonzogni A, Leon ME, Solli PG, Leo F, Spaggiari L, Bellomi M, Fazio F, Pastorino U. Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases. Br J Cancer. 2002 May 6;86(9):1391-5; IF 3.639

14        Spaggiari L, Solli P, Leo F, Veronesi G, Pastorino U. Anomalous segmental vein for right upper lobe: an unusual anatomical variation. Ann Thorac Surg. 2002 Jul;74(1):267; IF 2.052

15        Leo F, Solli P, Veronesi G, Spaggiari L, Pastorino U. Efficacy of microdrainage in severe subcutaneous emphysema. Chest. 2002 Oct;122(4):1498-9; IF 2.969

16        Spaggiari L, Solli P, Veronesi G, Pastorino U. Intrathoracic myoplasty for prosthesis infection after superior vena cava replacement for lung cancer. Ann Thorac Surg. 2002 Oct;74(4):1231-3; IF 2.052

17        Veronesi G, Spaggiari L, Solli PG, Leo F, Villa G, Pastorino U. Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma. Ann Oncol. 2002 Dec;13(12):1945-7; IF 3.114

18        Spaggiari L, Veronesi G, Solli P.  Resection of locally advanced thymic carcinoid tumors. Eur J Cardiothorac Surg. 2003 Feb;23(2):254; IF 1.465

19        Veronesi G, Spaggiari L, De Pas T, Solli PG, De Braud F, Catalano GP, Curigliano G, Leo F, Pastorino U. Preoperative chemotherapy is essential for conservative surgery of Askin tumors. J Thorac Cardiovasc Surg. 2003 Feb;125(2):428-9; IF 3.319

20        Spaggiari L, Solli P, Veronesi G.  Single lung resection of second primary after pneumonectomy for lung cancer. Ann Thorac Surg. 2003 Apr;75(4):1358; IF 2.041

21        Solli P, Leo F, Veronesi G, Curigliano G, Martinoni A, Spaggiari L, Cipolla C, Pastorino U. Impact of limited pulmonary function on the management of resectable lung cancer. Lung Cancer. 2003 Jul;41(1):71-9; IF 1.798

22        Trentin C, Veronesi G, Tosoni A, Bellomi M. Cardiac herniation after pneumonectomy: report of 2 cases. Radiol Med (Torino). 2003 Mar;105(3):230-3;

23        Spaggiari L, Veronesi G, Gasparri R, Pelosi G.  Synchronous bilateral lung carcinoid tumors: a rare entity? Eur J Cardiothorac Surg. 2003 Aug;24(2):334; IF 1.465

24        Veronesi G, Leon ME, Spaggiari L.  Safety of bronchoplastic resection after induction therapy for lung cancer. J Thorac Cardiovasc Surg. 2003 Nov;126(5):1670-1; author reply 1671; IF 3.319

25        Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG, Leo F, Spaggiari L, Pelosi G, Bellomi M, Fazio F. Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg. 2003 Dec;126(6):1906-10; IF 3.319

26        Leo F, Solli P, Spaggiari L, Veronesi G, de Braud F, Leon ME, Pastorino U.  Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg. 2004 Jan;77(1):260-5; discussion 265; IF 2.244

27        Pelosi G, Scarpa A, Manzotti M, Veronesi G, Spaggiari L, Fraggetta F, Nappi O, Benini E, Pasini F, Antonello D, Iannucci A, Maisonneuve P, Viale G. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol. 2004; IF 3.643

28        Veronesi G, Leo F, Spaggiari L. Salvage lung metastasectomy by video-assisted transmanubrial approach. Thorac Cardiovasc Surg. 2004 Apr;52(2):113-4. IF 0.753

29        Rabascio C, Muratori E, Mancuso P, Calleri A, Raia V, Foutz T, Cinieri S, Veronesi G, Pruneri G, Lampertico P, Iavarone M, Martinelli G, Goldhirsch A, Bertolini F. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res. 2004 Jun 15;64(12):4373-7. IF 0.753

30        Spaggiari L, Veronesi G, D'Aiuto M, Tosoni A. Superior vena cava reconstruction using heterologous pericardial tube after extended resection for lung cancer. Eur J Cardiothorac Surg. 2004 Sep;26(3):649-51. IF 1.616

31        Pelosi G, Masullo M, Leon ME, Veronesi G, Spaggiari L, Pasini F, Sonzogni A, Iannucci A, Bresaola E, Viale G. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch. 2004 Nov;445(5):449-55. Epub 2004 Sep 16. IF 2.227

32        Pelosi G, Del Curto B, Dell'Orto P, Pasini F, Veronesi G, Spaggiari L, Maisonneuve P, Iannucci A, Terzi A, Lonardoni A, Viale G.  Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung. Int J Cancer. 2005 Jan 1;113(1):101-8. IF 4.700

33        De Pas T, Curigliano G, Veronesi G, Catalano G, Catania C, Jereczek-Fossa B, Orecchia R, Spaggiari L, de Braud F Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study. Bull Cancer. 2004 Sep 1;91(9):E273-7. IF 0.654

34        De Pas T, Pelosi G, de Braud F, Veronesi G, Curigliano G, Leon ME, Danesi R, Noberasco C, d'Aiuto M, Catalano G, Viale G, Spaggiari L. Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare. J Clin Oncol. 2004 Dec 15;22(24):4966-70. IF 9.835

35        Spaggiari L, D' Aiuto M, Veronesi G, Pelosi G, de Pas T, Catalano G, de Braud F. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. Ann Thorac Surg. 2005 Jan;79(1):234-40. IF 2.229

36        Presicci PF, Veronesi G, D'Aiuto M, Spaggiari L. Long-term survival after salvage surgery for colorectal lung metastases. Ann Thorac Surg. 2005 Jan;79(1):325-6. IF 2.229

37        Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer. 2005 Mar 15;103(6):1154-64. IF 4.800

38        D'Aiuto M, Veronesi G, Pompilio G, Gasparri R, Presicci F, Galetta D, Biglioli P, Spaggiari L. Extended right pneumonectomy with partial left atrial resection for primary leiomyosarcoma of the mediastinum. J Thorac Cardiovasc Surg. 2005 Mar;129(3):694-5. IF 3.727

39        De Pas T, Sbanotto A, Catania C, Banfi MG, Curigliano G, Nole F, Fazio N, Formica V, Veronesi G, de Braud F. Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain. Support Care Cancer. 2005 Mar;13(3):194-5. Epub 2004 Nov 17. IF 1.590

40        De Braud F, De Pas T, Spaggiari L, Veronesi G, Curigliano G, Noberasco C, Pelosi G. Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 2005 Mar 16;97(6):461-2; author reply 462-3.  7. IF 15.171

41        Catalano G, Jereczek-Fossa BA, De Pas T, Leon ME, Cattani F, Spaggiari L, Veronesi G, de Braud F, Orecchia R. Three-Times-Daily Radiotherapy with Induction Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer Feasibility and Toxicity Study. Strahlenther Onkol. 2005 Jun;181(6):363-371. IF 3.490

42        Spaggiari L, Calabrese LS, D'Aiuto M, Veronesi G, Galetta D, Venturino M, Chiesa F.  Successful subtotal tracheal replacement (using a skin/omental graft) for dehiscence after a resection for thyroid cancer. J Thorac Cardiovasc Surg. 2005 Jun;129(6):1455-6. IF 3.727

43        D'Aiuto M, Veronesi G, Pelosi G, Presicci PF, Ferraroli GM, Gasparri R, Spaggiari L. Two-year survival after multiple bilateral lung metastasectomies for cranial meningioma. Ann Thorac Surg. 2005 Sep;80(3):1129-30.  IF 2.229

44        Pelosi G, Scarpa A, Veronesi G, Spaggiari L, Del Curto B, Moore PS, Maisonneuve P, Sonzogni A, Masullo M, Viale G.  A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression. Virchows Arch. 2005 Dec;447(6):969-77. Epub 2005 Sep 13.  IF 2.224

45        Pelosi G, Schianchi E, Dell'orto P, Veronesi G, Spaggiari L, Pasini F, Sozzi G, Brambilla E, Griso C, Viale G.   Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. Virchows Arch. 2006 Jan;448(1):7-15. Epub 2005 Sep 29. IF 2.251

46        De Pas T, Sbanotto A, Catania C, Banfi MG, Curigliano G, Nole F, Fazio N, Formica V, Veronesi G, de Braud F. Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain. Support Care Cancer. 2005 Mar;13(3):194-5. Epub 2004 Nov 17. IF 1.590

47        de Braud F, De Pas T, Spaggiari L, Veronesi G, Curigliano G, Noberasco C, Pelosi G. Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 2005 Mar 16;97(6):461-2; author reply 462-3. IF 15.171

48        Veronesi G, Pelosi G, Sonzogni A, Leon ME, D'Aiuto M, Gasparri R, De Braud F, De Pas T, Sandri M, Spaggiari L. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung. Lung Cancer. 2005 May;48(2):233-40. Epub 2004 Dec 23. IF 3.172

49        Catalano G, Jereczek-Fossa BA, De Pas T, Leon ME, Cattani F, Spaggiari L, Veronesi G, de Braud F, Orecchia R. Three-Times-Daily Radiotherapy with Induction Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer Feasibility and Toxicity Study. Strahlenther Onkol. 2005 Jun;181(6):363-371. IF 3.490

50        Spaggiari L, Calabrese LS, D'Aiuto M, Veronesi G, Galetta D, Venturino M, Chiesa F.  Successful subtotal tracheal replacement (using a skin/omental graft) for dehiscence after a resection for thyroid cancer. J Thorac Cardiovasc Surg. 2005 Jun;129(6):1455-6. IF 3.727

51        D'Aiuto M, Veronesi G, Peccatori FA, Pelosi G, Venturino M, Gasparri R, Presicci F, Galetta D, Spaggiari L. Mediastinal-like growing teratoma syndrome. J Thorac Cardiovasc Surg. 2005 Jul;130(1):228-9. IF 3.727

52        Gasparri R, Leo F, Veronesi G, De Pas T, Colleoni M, Maisonneuve P, Pelosi G, Galimberti V, Spaggiari L. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer. 2006 Jan 15;106(2):271-6. Erratum in: Cancer. 2006 Sep 15;107(6):1421; IF 4.582

53        Spaggiari L, Galetta D, Veronesi G, Leo F, Gasparri R, Petrella F, Borri A, Pelosi G, Venturino M.  Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. J Thorac Cardiovasc Surg. 2006 Feb;131(2):490-1. IF 3.560

54        Veronesi G, Scanagatta P, Leo F, Petrella F, Galetta D, Gasparri R, Borri A, Pelosi G, Leon ME, Spaggiari L.   Subclavicular recurrence of breast cancer: does surgery play a role? Breast. 2006 Oct;15(5):649-53. Epub 2006 Apr 18. 

55        Veronesi G, Morandi U, Alloisio M, Terzi A, Cardillo G, Filosso P, Rea F, Facciolo F, Pelosi G, Gandini S, Calabro F, Casali C, Marulli G, Spaggiari L.   Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer. 2006 Jul;53(1):111-5. Epub 2006 May 11.  IF  3.554

56        Leo F, Solli P, Veronesi G, Galetta D, Petrella F, Gasparri R, Borri A, Spaggiari L. Review on bronchopleural fistula: did a surgeon review it? Chest. 2006 Jun;129(6):1731 ; IF 3.924

57        Leo F, Borri A, Petrella F, Gasparri R, Galetta D, Veronesi G, Spaggiari L.   Preoperative chemotherapy and postoperative complications: a closer look. Ann Thorac Surg. 2006 Jun;81(6):2335. No abstract available. IF 2.342

58        Galetta D, Veronesi G, Leo F, Spaggiari L.   Pulmonary artery reconstruction by a custom-made heterologous pericardial conduit in the treatment of lung cancer. Lung Cancer. 2006 Aug;53(2):241-3. Epub 2006 Jun 19.  IF  3.554

59        Leo F, Solli P, Veronesi G, Radice D, Floridi A, Gasparri R, Petrella F, Borri A, Galetta D, Spaggiari L.   Does chemotherapy increase the risk of respiratory complications after pneumonectomy? J Thorac Cardiovasc Surg. 2006 Sep;132(3):519-23.  IF 3.560

60        Borri A, Leo F, Galetta D, Veronesi G, Solli P, Petrella F, Gasparri R, Scanagatta P, Spaggiari L.  Technique, results and impact of induction chemotherapy in sleeve lobectomy for lung cancer. Minerva Chir. 2006 Aug;61(4):307-313.

61        Petrella F, Veronesi G, Leo F, Solli P, Borri A, Gasparri R, Galetta D, Scanagatta P, Spaggiari L.  Extended redo sleeve resection for postoperative dehiscence after right upper bronchoplasty Minerva Chir. 2006 Aug;61(4):353-5. 

62        Galetta D, Veronesi G, Leo F, Solli P, Spaggiari L.  Anomalous right upper lobe venous drainage. Ann Thorac Surg. 2006 Dec;82(6):2272-4. IF 2.342

63        Spaggiari L, Leo F, Veronesi G, Solli P, Galetta D, Tatani B, Petrella F, Radice D.   Superior vena cava resection for lung and mediastinal malignancies: a single-center Experience with 70 cases. Ann Thorac Surg. 2007 Jan;83(1):223-9; discussion 229-30. IF 2.022

64        De Pas TM, de Braud F, Catalano G, Putzu C, Veronesi G, Leo F, Solli PG, Brambilla D, Paganelli G, Spaggiari L.  Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. Ann Thorac Surg. 2007 Jan;83(1):231-4. IF 2.022

65        Veronesi G, Scanagatta P, Goldhirsch A, Rietjens M, Colleoni M, Pelosi G, Spaggiari L. Results of chest wall resection for recurrent or locally advanced breast malignancies. Breast. 2007 Feb 10

66        Leo F, Scanagatta P, Baglio P, Radice D, Veronesi G, Solli P, Petrella F, Spaggiari L. The risk of pneumonectomy over the age of 70. A case-control study. Eur J Cardiothorac Surg. 2007 May;31(5):780-3. Epub 2007 Feb 22. IF 2.011

67        Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Salvatici M, Veronesi G, Veglia F, Fiorentini C, Spaggiari L, Cipolla CM. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 2007 Mar 20;115(11):1339-44. IF 12.755

68        Galetta D, Veronesi G, Solli P, Petrella F, Borri A, Gasparri R, Leo F, Spaggiari L. A safe and effective method for an immediate bronchopleural fistula repair. Minerva Chir. 2007 Apr;62(2):137-9.

69        Veronesi G, Petrella F, Leo F, Solli P, Maissoneuve P, Galetta D, Gasparri R, Pelosi G, De Pas T, Spaggiari L.  Prognostic role of lymph node involvement in lung metastasectomy. J Thorac Cardiovasc Surg. 2007 Apr;133(4):967-72. Epub 2007 Feb 26.  IF 3.354

70        Pelosi G, Del Curto B, Trubia M, Nicholson AG, Manzotti M, Veronesi G, Spaggiari L, Maisonneuve P, Pasini F, Terzi A, Iannucci A, Viale G.  3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res. 2007 Apr 1;13(7):1995-2004. IF 6.250

71        Pelosi G, Leon ME, Veronesi G, Spaggiari L, Pasini F, Viale G.  Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors. J Thorac Oncol. 2006 Jun;1(5):468-77.

72        Veronesi G, Scanagatta P, Leo F, De Pas T, Pelosi G, Catalano G, Gandini S, De Braud F, Spaggiari L. Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer. J Thorac Oncol. 2007 Feb;2(2):131-4. IF 4.473

73        Leo F, De Pas T, Catalano G, Piperno G, Curigliano G, Solli P, Veronesi G, Petrella F, Spaggiari L.Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.J Natl Cancer Inst. 2007 Aug 1;99(15):1210; author reply 1210-1. IF 15.678

74        Spaggiari L, Veronesi G, Bellomi M, Maisonneuve P. Computed tomography screening for lung cancer.JAMA. 2007 Aug 1;298(5):514; author reply 515-6.

75        Veronesi G, Bellomi M, Veronesi U, Paganelli G, Maisonneuve P, Scanagatta P, Leo F, Pelosi G, Travaini L, Rampinelli C, Trifirò G, Sonzogni A, Spaggiari L. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg. 2007 Sep;84(3):959-65; discussion 965-6. IF 2.022

76        Galetta D, Pelosi G, Leo F, Solli P, Veronesi G, Borri A, Gasparri R, Petrella F, Di Tonno C, Del Curto B, Spaggiari L. Primary thoracic synovial sarcoma: factors affecting long-term survival. J Thorac Cardiovasc Surg. 2007 Sep;134(3):808-9. IF 3.354

77        Bellomi M, Veronesi G, Rampinelli C, Ferretti S, De Fiori E, Maisonneuve P.Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokers. Br J Radiol. 2007 Sep;80(957):708-12.  IF 1.773

78        Borri A, Leo F, Veronesi G, Solli P, Galetta D, Gasparri R, Petrella F, Scanagatta P, Radice D, Spaggiari L. Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J Thorac Cardiovasc Surg. 2007 Nov;134(5):1266-72 ; IF 3.354

79        Veronesi G, Bellomi M, Spaggiari L. The rate of incidental findings in lung cancer screening trials is not negligible. Eur Radiol. 2008 Mar;18(3):529.  IF 3.651

80        Petrella F, Leo F, Veronesi G, Solli P, Borri A, Galetta D, Gasparri R, Lembo R, Radice D, Scanagatta P, Spaggiari L. "Salvage" surgery for primary mediastinal malignancies: is it worthwhile? J Thorac Oncol. 2008 Jan;3(1):53-8. IF 17.157

81        Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, Maisonneuve P, Preda L, Leo F, Bertolotti R, Solli P, Spaggiari L. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008 Sep;61(3):340-9. Epub 2008 Mar 4. IF 2.970

82        Pelosi G, Sonzogni A, Veronesi G, De Camilli E, Maisonneuve P, Spaggiari L, Manzotti M, Masullo M, Taliento G, Fumagalli C, Bellomi M, Travis WD, Kadivar M, Viale G. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. Lung Cancer. 2008 Nov;62(2):202-14.  IF 2.970

83        Veronesi G, Bellomi M, Scanagatta P, Preda L, Rampinelli C, Guarize J, Pelosi G, Maisonneuve P, Leo F, Solli P, Masullo M, Spaggiari L. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg. 2008 Sep;136(3):611-7. IF 3.037

84        De Cicco C, Bellomi M, Bartolomei M, Carbone G, Pelosi G, Veronesi G, De Pas T, Spaggiari L, Paganelli G. Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography. Ann Thorac Surg. 2008 Dec;86(6):1769-72.  IF 2.689

85        Pelosi G, Sonzogni A, De Pas T, Galetta D, Veronesi G, Spaggiari L, Manzotti M, Fumagalli C, Bresaola E, Nappi O, Viale G, Rosai J. Pulmonary Sarcomatoid Carcinomas: A Practical Overview. Int J Surg Pathol. 2009 Jan 14. IF 0.912

86        Catalano G, De Pas T, Spaggiari L, Gandini S, Jereczek-Fossa BA, De Braud F, Leo F, Veronesi G, Orecchia R. Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study. Anticancer Res. 2008 Nov-Dec;28(6B):4121-7. IF 1.390

87        Petrella F, Chieco P, Solli P, Veronesi G, Borri A, Galetta D, Gasparri R, Spaggiari L. Which factors affect pulmonary function after lung metastasectomy? Eur J Cardiothorac Surg. 2009 May;35(5):792-6. Epub 2009 Feb 23. IF 2.397

 

88        Bellomi M, Rampinelli C, Veronesi G, Harari S, Lanfranchi F, Raimondi S, Maisonneuve P. Evolution of emphysema in relation to smoking. Eur Radiol. 2010 Feb;20(2):286-92. Epub 2009 Aug 25. IF 3.594

89        Paradiso A, Mangia A, Orlando C, Veronesi G et al. The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. Int J Biol Markers. 2009 Jul-Sep;24(3):119-29. IF 1.419

90        Bellomi M, Rampinelli C, De Fiori E, Preda L, Veronesi G. Lung cancer screening update. Cancer Imaging. 2009 Oct 2;9 Spec No A:S122-5. Review.

91        Veronesi G, Galetta D, Maisonneuve P, Melfi F, Schmid RA, Borri A, Vannucci F, Spaggiari L . Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg. 2009 Dec 26. IF 3.037

92        Petrella F, Rizzo S, Solli P, Borri A, Galetta D, Gasparri R, Veronesi G, Spaggiari L Intraparenchymal pulmonary artery aneurysm from ipsilobar non-small cell lung cancer. J Thorac Oncol. 2010 Feb;5(2):258-9. No abstract available.  IF 4.040

93        Pas TD, Raimondi S, Pelosi G, Spaggiari L, Braud FD, Veronesi G, Maisonneuve P. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer. Acta Oncol. 2010 Jan 28. IF 3.137

94        Bellomi M, Maisonneuve P, Raimondi S, Veronesi G Reply to Letter to the Editor re: Evolution of emphysema in relation to smoking. Eur Radiol. 2010 Feb 24. IF 3.594

95        Petrella F, Pruneri GC, Ghioni M, Borri A, Galetta D, Gasparri R, Solli P, Veronesi G, Spaggiari L. Synchronous primary lung cancer, breast cancer recurrence, and mediastinal silicon-induced lymphadenitis. J Thorac Oncol. 2010 Apr;5(4):560-1.  IF 4.040

96        De Pas T, de Braud F, Veronesi G. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process. J Thorac Oncol. 2010 May;5(5):754. No abstract available. IF 4.040

97        Rinaudo C, Croce A, Musa M, Fornero E, Allegrina M, Trivero P, Bellis D, Sferch D, Toffalorio F, Veronesi G, Pelosi G Study of inorganic particles, fibers, and asbestos bodies by variable pressure scanning electron microscopy with annexed energy dispersive spectroscopy and micro-Raman spectroscopy in thin sections of lung and pleural plaque. Appl Spectrosc. 2010 Jun;64(6):571-7. IF 1.729

98        Avila RS, Zulueta JJ, Shara NM, Jansen K, Veronesi G, Wang H, Mulshine JL. A quantitative method for estimating individual lung cancer risk. Acad Radiol. 2010 Jul;17(7):830-40. IF 2.195

99        Rampinelli C, Raimondi S, Padrenostro M, De Fiori E, Meroni S, Veronesi G, Bellomi M. Pulmonary nodules: Contrast-enhanced volumetric variation at different CT scan delays. AJR Am J Roentgenol. 2010 Jul;195(1):149-54. IF 2.797

100      Petrella F, Rizzo S, Pelosi G, Borri A, Galetta D, Gasparri R, Solli P, Veronesi G, Spaggiari L. Giant alveolar adenoma causing severe dyspnoea. J Thorac Oncol. 2010 Jul;5(7):1088-90. No abstract available.  IF 4.040

101      Lazzeroni M, Guerrieri-Gonzaga A, Serrano D, Varricchio MC, Veronesi G, Radice D, Feroce I, Nardi-Pantoli A, Lippman SM, Szabo E, Bonanni B Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology.. Contemp Clin Trials. 2010 Nov;31(6):612-9. Epub 2010 Aug 16. IF 1.698

102      Veronesi G, Maisonneuve P, De Pas TM, Bellomi M Does lung cancer screening with low-dose CT remain promising despite disappointing DANTE results?.  Am J Respir Crit Care Med. 2010 Sep 1;182(5):720-1; author reply 721. No abstract available. IF 10.191

103      Petrella F, Radice D, Borri A, Galetta D, Gasparri R, Solli P, Veronesi G, Spaggiari The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies. L  Eur J Cardiothorac Surg. 2010 Oct 15. IF 2.293

104      Belloni E, Veronesi G, Micucci C, Javan S, Minardi SP, Venturini E, Maisonneuve P,